Type 2 diabetes is relatively widespread in Japan, and that nation’s Ministry of Health, Labour and Welfare estimates that nearly one-third of all individuals over the age of 40 are either diabetic or pre-diabetic.
Intriguingly, Japanese patients as a whole are less prone to obesity, a condition commonly associated with onset of type 2 diabetes in the Western world, indicating that there may be some significant differences in disease pathology between these two groups.
Two primary mechanisms contribute to the onset of type 2 diabetes. Fat, muscle and liver cells lose the ability to respond to the hormone insulin, a state known as ‘insulin resistance’ that greatly reduces the efficiency with which excess glucose is taken up from the bloodstream; in parallel, the capacity of the pancreatic beta cells to produce and secrete additional insulin is impaired.
However, Shiro Maeda of the RIKEN Center for Genomic Medicine in Yokohama points out that the relative importance of these mechanisms appears to differ between Eastern and Western populations. “Accumulating clinical evidence suggests that disability of insulin secretion contributes more to the pathogenesis of Japanese type 2 diabetes,” he says, “whereas insulin resistance seems more important for European type 2 diabetes.”
Getting the big picture
Very little is known about the genetic-level differences in pathology between the Japanese and Europeans. From several previous genome-wide association studies (GWAS), geneticists have identified several small sequence changes, also known as single-nucleotide polymorphisms (SNPs), which might be located near or within genes involved in type 2 diabetes. They have also identified several of these ‘susceptibility loci’. However, with the exception of a few small-scale Japanese studies, nearly all of these data were obtained exclusively from individuals of European ancestry.
In an effort to collect more information about Japanese-specific risk factors, Maeda and Takashi Kadowaki of The University of Tokyo recently headed up a large GWAS that matches the scale of its European counterparts both in terms of the numbers of subjects involved and in the number of genomic markers examined1. According to Maeda, their study of some 5,000 type 2 diabetes subjects and 3,000 controls for 459,359 SNPs, is one of the largest sample sizes for a single GWAS worldwide.
Maeda, Kadowaki and colleagues subjected 98 candidate SNPs with the strongest association to type 2 diabetes to an additional round of analysis in a second, independent, set of disease and control cohorts. Based on these data, they identified statistically significant disease linkage for SNPs at a number of different genomic loci (Fig. 2). One of these SNPs, KCNQ1, was identified in both of the previous Japanese GWAS as a risk factor in both Asians and Europeans, and this gene appears to participate in the regulation of glucose-induced insulin secretion.
The researchers’ study also flagged SNPs at two additional loci for which no association to type 2 diabetes had been previously reported. Both of these loci were subsequently validated in yet a third round of genomic screening, reinforcing the likelihood of their connection to diabetes.
Enigmatic risk factors
One of the newly identified loci, UBE2E2, encodes an enzyme that targets proteins for destruction by marking them with individual molecules of the small protein ubiquitin. It is expressed in a variety of tissues, including the liver, pancreas, muscle and fat. Based on several recent studies, researchers have suggested that the ubiquitination pathway may contribute to the efficient synthesis and secretion of insulin. Maeda, Kadowaki and colleagues noted that study subjects with the diabetes risk-associated UBE2E2 allele appeared to exhibit impairments in insulin regulation.
Strikingly, although the SNPs at this locus were also determined to be associated with type 2 diabetes for three other East Asian populations, in addition to various Japanese study groups, this association was not statistically significant for two European groups, consisting of a total of 6,980 subjects and 8,615 controls. “Although this population-specific effect needs to be validated further, the present study is the first to show the existence of a disease-susceptibility locus [for diabetes] in a population-specific manner with genome-wide significant levels of association,” says Maeda.
Despite escaping detection in previous large-scale GWAS, the second newly identified locus, C2CD4A-C2CD4B, showed significant association with type 2 diabetes in both Asian and European cohorts. C2CD4A-C2CD4B produces a pair of factors that appear to contribute to the maintenance of cell structure, and although relatively little is known about their function, both factors are expressed in many of the same tissues as UBE2E2. This represents the first indication that they might contribute to the pathology of type 2 diabetes.
Kadowaki, Maeda and colleagues are now scanning these two loci more carefully in an effort to identify potential mechanisms by which sequence variants in these regions might contribute to onset of diabetes. Maeda indicates that they are particularly keen to understand the biological basis for the apparent ethnicity-specific disease association of SNPs in the UBE2E2 locus.
At the same time, the identification of a novel locus that appears to contribute to risk of diabetes across population lines suggests that there may be a number of other susceptibility genes waiting to be discovered. “The identification of C2CD4A-C2CD4B as a common locus is really surprising, because this important locus has been missed in European GWAS,” says Maeda, “[and] we are now participating in international collaborations, both East Asian and trans-ethnic, to identify additional type 2 diabetes susceptibility loci.”
Shiro MaedaShiro Maeda was born in 1960 and is currently Laboratory Head at the Laboratory for Endocrinology and Metabolism, RIKEN Center for Genomic Medicine, where his research area is genetics for diabetic nephropathy and type 2 diabetes. He received his MD and PhD from Shiga University of Medical Science. He worked as a physician at Koka Public Hospital and Shiga University of Medical Science for next three years. From 1993 to 1996 he was a research fellow at the Department of Pathology, University of Michigan, where he researched osmotic response elements within the ALR2 gene. For the next two years, he did a residency at Shiga University of Medical Science in internal medicine, and emergency and critical medicine. In 1999, he was an instructor for the Third Department of Medicine, Shiga University of Medical Science, and then joined RIKEN the following year as a research scientist in the Laboratory for Genotyping, SNP Research Center. He was a Laboratory head at Laboratory for Diabetic Nephropathy between 2001 and 2008, and has been in his current post since 2008.
Seeing on the Quick: New Insights into Active Vision in the Brain
15.08.2018 | Eberhard Karls Universität Tübingen
New Approach to Treating Chronic Itch
15.08.2018 | Universität Zürich
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur
What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...
08.08.2018 | Event News
27.07.2018 | Event News
25.07.2018 | Event News
15.08.2018 | Physics and Astronomy
15.08.2018 | Earth Sciences
15.08.2018 | Physics and Astronomy